4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001019056-18-000416
Chief Medical Officer and SVP acquired 16,269 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stromatt Scott C Chief Medical Officer and SVP | 2018-03-01 | Option exercise | +16,269 | 190,845 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Stromatt Scott C Chief Medical Officer and SVP | 2018-03-01 | Option exercise · Restricted Stock Unit | −16,269 | 30,161 | D: show line 2 in the form |
Loading xslF345X03/stromatt_4.xml…